UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical development of metabolic inhibitors for oncology

The Journal of clinical investigation, 2022-01, Vol.132 (1), p.1-15

2022

Volltextzugriff (PDF)

Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network

Journal of medicinal chemistry, 2021-01, Vol.64 (1), p.279-297

2021

Volltextzugriff (PDF)

We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine

Molecular cancer therapeutics, 2018-09, Vol.17 (9), p.1824-1832

2018

Volltextzugriff (PDF)

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Science (American Association for the Advancement of Science), 2019-11, Vol.366 (6468), p.1013-1021

2019

Volltextzugriff (PDF)

Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting

European journal of pharmacology, 2012-06, Vol.684 (1-3), p.1-7

2012

Volltextzugriff (PDF)

Preventing Allograft Rejection by Targeting Immune Metabolism

Cell reports (Cambridge), 2015-10, Vol.13 (4), p.760-770

2015

Volltextzugriff (PDF)

Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties

PloS one, 2015-05, Vol.10 (5), p.e0124481-e0124481

2015

Volltextzugriff (PDF)

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Nature reviews. Neurology, 2016-04, Vol.12 (4), p.234-248

2016

Volltextzugriff (PDF)

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3865-3884

2020

Volltextzugriff (PDF)

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

The Journal of clinical investigation, 2015-06, Vol.125 (6), p.2293-2306

2015

Volltextzugriff (PDF)

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Proceedings of the National Academy of Sciences - PNAS, 2016-09, Vol.113 (36), p.E5328-E5336

2016

Volltextzugriff (PDF)

Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs

Advances in pharmacology (1990), 2024, Vol.100, p.157

2024

Volltextzugriff (PDF)

Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain

Neurobiology of disease, 2016-10, Vol.94, p.116-128

2016

Volltextzugriff (PDF)

Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons

Neurobiology of disease, 2023-02, Vol.177, p.105987, Article 105987

2023

Volltextzugriff (PDF)

Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects

European journal of pharmacology, 2012-08, Vol.689 (1-3), p.25-30

2012

Volltextzugriff (PDF)

Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination

The Journal of neuroscience, 2016-08, Vol.36 (34), p.8783-8789

2016

Volltextzugriff (PDF)

Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases

Drug discovery today, 2021-07, Vol.26 (7), p.1656-1668

2021

Volltextzugriff (PDF)

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

Science translational medicine, 2023-08, Vol.15 (708), p.eabn7491

2023

Volltextzugriff (PDF)

GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice

International journal of molecular sciences, 2024-06, Vol.25 (13), p.6893

2024

Volltextzugriff (PDF)

Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain

Journal of medicinal chemistry, 2017-09, Vol.60 (18), p.7799-7809

2017

Volltextzugriff (PDF)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis

Nature communications, 2023-11, Vol.14 (1), p.7427-7427, Article 7427

2023

Volltextzugriff (PDF)

Discovery of 6‑Diazo-5-oxo‑l‑norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma

Journal of medicinal chemistry, 2016-09, Vol.59 (18), p.8621-8633

2016

Volltextzugriff (PDF)

MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice

Proceedings of the National Academy of Sciences - PNAS, 2018-12, Vol.115 (51), p.E12024-E12033

2018

Volltextzugriff (PDF)

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

PloS one, 2015-07, Vol.10 (7), p.e0131861-e0131861

2015

Volltextzugriff (PDF)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer

Advanced science, 2022-09, Vol.9 (26), p.e2105885-n/a

2022

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)

Publikationsform

Artikel
(197)

Sprache

Englisch
(197)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(164)
Mice
(101)
Humans
(90)
Male
(88)
Pharmacology & Pharmacy
(76)
Rats
(69)
Neurosciences
(57)
Neurosciences & Neurology
(57)
Biological And Medical Sciences
(41)
Glutamate Carboxypeptidase Ii
(36)
Glutamate Carboxypeptidase Ii - Antagonists & Inhibitors
(35)
Chemistry, Medicinal
(34)
Female
(34)
Dose-Response Relationship, Drug
(33)
Enzyme Inhibitors - Pharmacology
(33)
Medical Sciences
(33)
Rats, Sprague-Dawley
(33)
Biochemistry & Molecular Biology
(32)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical development of metabolic inhibitors for oncology

Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network

We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting

Preventing Allograft Rejection by Targeting Immune Metabolism

Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs

Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain

Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons

Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects

Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination

Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice

Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis

Discovery of 6‑Diazo-5-oxo‑l‑norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma

MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer

Aktive Filter

Suchergebnisse filtern